JP2002522376A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002522376A5 JP2002522376A5 JP2000563255A JP2000563255A JP2002522376A5 JP 2002522376 A5 JP2002522376 A5 JP 2002522376A5 JP 2000563255 A JP2000563255 A JP 2000563255A JP 2000563255 A JP2000563255 A JP 2000563255A JP 2002522376 A5 JP2002522376 A5 JP 2002522376A5
- Authority
- JP
- Japan
- Prior art keywords
- xanthan gum
- composition according
- active ingredient
- solid
- solid composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9816723.2A GB9816723D0 (en) | 1998-08-01 | 1998-08-01 | Therapeutic agents |
| GB9816723.2 | 1998-08-01 | ||
| PCT/EP1999/005499 WO2000007569A1 (en) | 1998-08-01 | 1999-07-28 | Compressed compositions comprising clarified xanthan gum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002522376A JP2002522376A (ja) | 2002-07-23 |
| JP2002522376A5 true JP2002522376A5 (enExample) | 2006-06-29 |
Family
ID=10836508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000563255A Pending JP2002522376A (ja) | 1998-08-01 | 1999-07-28 | 清澄キサンタンガムを含有する圧縮組成物 |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1100471B1 (enExample) |
| JP (1) | JP2002522376A (enExample) |
| CN (1) | CN1160060C (enExample) |
| AR (1) | AR019981A1 (enExample) |
| AT (1) | ATE249815T1 (enExample) |
| AU (1) | AU744483B2 (enExample) |
| CA (1) | CA2339190C (enExample) |
| DE (1) | DE69911427T2 (enExample) |
| DK (1) | DK1100471T3 (enExample) |
| ES (1) | ES2207274T3 (enExample) |
| GB (1) | GB9816723D0 (enExample) |
| MX (1) | MXPA01000992A (enExample) |
| NZ (1) | NZ509593A (enExample) |
| PT (1) | PT1100471E (enExample) |
| WO (1) | WO2000007569A1 (enExample) |
| ZA (1) | ZA200100828B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030034171A (ko) | 2001-07-06 | 2003-05-01 | 엔도 파마슈티걸즈, 인크. | 옥시모르폰 제어 방출 제형 |
| WO2003026743A2 (en) * | 2001-09-26 | 2003-04-03 | Penwest Pharmaceuticals Company | Opioid formulations having reduced potential for abuse |
| CN117752805B (zh) * | 2023-12-25 | 2024-12-24 | 山东聊城阿华制药股份有限公司 | 一种药用辅料及其制备方法 |
| KR102881485B1 (ko) * | 2024-03-22 | 2025-11-05 | (주) 팜젠사이언스 | 천연첨가제에 기반한 비타민c 조성물 및 이를 포함하는 지속성 비타민c 정제 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4135979A (en) * | 1976-08-24 | 1979-01-23 | Merck & Co., Inc. | Treatment of xanthan gum to improve clarity |
| GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
| US4915948A (en) * | 1987-08-31 | 1990-04-10 | Warner-Lambert Company | Tablets having improved bioadhesion to mucous membranes |
| EP0399774A1 (en) * | 1989-05-24 | 1990-11-28 | Merck & Co. Inc. | Composition and method for rheology controlled printing of fabric and carpet |
-
1998
- 1998-08-01 GB GBGB9816723.2A patent/GB9816723D0/en not_active Ceased
-
1999
- 1999-07-28 CA CA002339190A patent/CA2339190C/en not_active Expired - Fee Related
- 1999-07-28 NZ NZ509593A patent/NZ509593A/xx unknown
- 1999-07-28 DK DK99941487T patent/DK1100471T3/da active
- 1999-07-28 AU AU55087/99A patent/AU744483B2/en not_active Ceased
- 1999-07-28 MX MXPA01000992A patent/MXPA01000992A/es unknown
- 1999-07-28 WO PCT/EP1999/005499 patent/WO2000007569A1/en not_active Ceased
- 1999-07-28 PT PT99941487T patent/PT1100471E/pt unknown
- 1999-07-28 JP JP2000563255A patent/JP2002522376A/ja active Pending
- 1999-07-28 AT AT99941487T patent/ATE249815T1/de not_active IP Right Cessation
- 1999-07-28 EP EP99941487A patent/EP1100471B1/en not_active Expired - Lifetime
- 1999-07-28 ES ES99941487T patent/ES2207274T3/es not_active Expired - Lifetime
- 1999-07-28 CN CNB998113735A patent/CN1160060C/zh not_active Expired - Fee Related
- 1999-07-28 DE DE69911427T patent/DE69911427T2/de not_active Expired - Fee Related
- 1999-07-30 AR ARP990103817A patent/AR019981A1/es unknown
-
2001
- 2001-01-30 ZA ZA200100828A patent/ZA200100828B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5572616B2 (ja) | 口腔内分散性多層錠剤 | |
| ES2319266T3 (es) | Comprimidos efervescentes bucodispersables. | |
| AU2004202702B2 (en) | Compositions comprising sympathomimetic amine salts unsuitable for illegal use | |
| AU2004246837B2 (en) | Orally-dispersible multilayer tablet | |
| JP2001510785A (ja) | 速崩壊性口内溶解錠の製造に適した顆粒の製造方法 | |
| HU217818B (hu) | Eljárás magas hatóanyag-tartalmú granulátumok, pelletek és tabletták előállítására | |
| US20170165212A1 (en) | Transdermal administration of tamsulosin | |
| NO175763C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat hvor DL-tryptofan, eventuelt i kombinasjon med fumarsyre, anvendes som hjelpestoffer | |
| HU202103B (en) | Process for producing effervescent pharmaceutical compositions containing ibuprofen | |
| DE69816951D1 (de) | Zubereitung enthaltend Cefaclor oder Cephalexin mit modifizierter Freisetzungsmatrix | |
| CN1380829A (zh) | 可迅速崩解的片剂及其制备方法 | |
| EP0974365A1 (fr) | Utilisation d'un polymère de type acrylique en tant qu'agent de désagrégation | |
| JP2007506774A5 (enExample) | ||
| TW200407175A (en) | Dosage form of sodium IBUPROFEN | |
| JP2005002009A (ja) | フェンタニル含有口腔粘膜貼付剤 | |
| CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
| JP2012255018A (ja) | 感覚器官的に許容されるイブプロフェン経口投与用製剤、該製剤の製法並びに使用法 | |
| JP2002537232A5 (enExample) | ||
| JPH0617300B2 (ja) | 歯周疾患治療用組成物 | |
| JPS6117510A (ja) | 口腔粘膜適用徐放性ニフエジピン製剤 | |
| YU81101A (sh) | Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija | |
| JPS63250318A (ja) | 口腔内に適用する製剤 | |
| CA2339190A1 (en) | Compressed compositions comprising clarified xanthan gum | |
| CA2520813A1 (en) | Sustained release formulations of alkylene dioxybenzene derivatives useful as 5-ht1a agonists | |
| JPS63250319A (ja) | 口腔内に適用する製剤 |